|
Originally published In Press as doi:10.1074/jbc.M109163200 on November 12, 2001
J. Biol. Chem., Vol. 277, Issue 6, 4343-4350, February 8, 2002
Structure and Mechanism of CTP:Phosphocholine
Cytidylyltransferase (LicC) from Streptococcus
pneumoniae*
Bo-Yeon
Kwak ,
Yong-Mei
Zhang§,
Mikyung
Yun ,
Richard J.
Heath§,
Charles O.
Rock§¶,
Suzanne
Jackowski§¶, and
Hee-Won
Park ¶
From the Department of Structural Biology and the
§ Protein Science Division, Department of Infectious
Diseases, St. Jude Children's Research Hospital, Memphis,
Tennessee 38105 and the ¶ Department of Molecular Biosciences,
University of Tennessee Health Science Center,
Memphis, Tennessee 38163
Received for publication, September 21, 2001, and in revised form, November 8, 2001
 |
ABSTRACT |
Pneumococcal LicC is a member of the nucleoside
triphosphate transferase superfamily and catalyzes the transfer of a
cytidine monophosphate from CTP to phosphocholine to form CDP-choline. The structures of apo-LicC and the
LicC·CDP-choline·Mg2+ ternary complex were
determined, and the comparison of these structures reveals a
significant conformational change driven by the multivalent
coordination of Mg2+. The key event is breaking the
Glu216·Arg129 salt bridge, which triggers the
coalescence of four individual -strands into two extended
-sheets. These movements reorient the side chains of
Trp136 and Tyr190 for the optimal binding and
alignment of the phosphocholine moiety. Consistent with these
conformational changes, LicC operates via a compulsory ordered kinetic
mechanism. The structures explain the substrate specificity of LicC for
CTP and phosphocholine and implicate a direct role for Mg2+
in aligning phosphocholine for in-line nucleophilic attack and stabilizing the negative charge that develops in the pentacoordinate transition state. These results provide a structural basis for assigning a specific role for magnesium in the catalytic mechanism of
pneumococcal LicC.
 |
INTRODUCTION |
Choline metabolism plays a key role in cell separation,
transformation, autolysis, and pathogenicity of Streptococcus
pneumoniae. The only known metabolic fate of choline is to
decorate the teichoic and lipoteichoic acids of the cell wall, and
choline is an essential nutrient for S. pneumoniae (1). The
cell surface P-Cho1
facilitates the interaction with the host surface and induces attachment and invasion (2, 3). The importance of choline in
pathogenesis is not confined to S. pneumoniae but also plays a role in Hemophilus influenzae (4-7), Pseudomonas
aeruginosa, and Neisseria gonorrhoeae (8, 9). In
addition, cell wall P-Cho serves as the scaffold for a group of
choline-binding proteins that are secreted from the cells and
subsequently attached to the cell surface by their homologous
choline-binding domains (see Ref. 10 and references therein). These
choline-binding proteins are essential for many aspects of S. pneumoniae cell physiology including competence and stationary
phase lysis.
The pathway for choline metabolism in S. pneumoniae and
H. influenzae has been hypothesized to consist of a choline
transport system, a choline kinase, CTP:phosphocholine
cytidylyltransferase (CCT), and a choline phosphotransferase that
transfers P-Cho from CDP-Cho to either lipoteichoic acid or
lipopolysaccharide (5). The existence of this pathway is supported by
the detection of choline kinase and CCT activity in crude extracts of
S. pneumoniae (11, 12). Genetic elements required for
choline incorporation into the lipopolysaccharide of H. influenzae are found in the lic1 locus, which contains
four open reading frames. The hypothesis drawn from the bioinformatic
analysis of the lic1 locus (4) is that licA
corresponds to choline kinase based on a 31% identity to the choline
kinase of Saccharomyces cerevisiae over the short span of 40 amino acids between residues 222 and 262. The licB gene has
several predicted transmembrane domains and is thus postulated to be a
choline transporter. The hydrophilic licC gene product is a
candidate for the CCT due to the resemblance of its amino terminus to
the amino-terminal 60 residues of NTP transferase family members,
leaving the licD gene as a candidate for the choline phosphotransferase. A homologous licC gene exists in
S. pneumoniae (13), and the predicted LicC proteins of
H. influenzae and S. pneumoniae are 37%
identical and 60% similar.
Recently, the LicC of S. pneumoniae was purified and
demonstrated to catalyze the CCT reaction (14). The enzyme possesses a
high degree of selectivity for P-Cho and CTP, although
phosphoethanolamine and ATP are poor substrates. LicC lacks homology to
either the prototypical metazoan CCTs (15, 16) or the
CTP:glycerol-3-phosphate cytidylyltransferase from Bacillus
subtilis (17). Rather, LicC is related to members of the NTP
transferase superfamily that primarily activate sugars by transferring
the NMP moiety to a phosphorylated acceptor substrate concomitant with
the release of PPi (see the NCBI Conserved Domain Database,
protein family 00483) and contain the N-terminal signature sequence
KAX5GXGTRX6-9K. The inclusion of LicC in this family is based on its similarity to the
amino termini of Escherichia coli GalU and P. aeruginosa RmlA, two prototypical nucleotidyltransferases that
form NDP-hexose derivatives that are used in the biosynthesis of
bacterial cell wall components (14). Members of this superfamily are
characteristically dimers or tetramers; however, LicC is a monomer
(14).
The crystal structures of three members of the NTP transferase
superfamily are known. These are the dimeric GlmU (18) and methylerythritol-4-phosphate cytidylyltransferase from E. coli (19) and the tetrameric RmlA from both P. aeruginosa (20) and Salmonella enterica (21). The NMP
transferase domains of these enzymes have a similar overall folding,
and they share several key residues involved in substrate binding
and/or catalysis, such as Gly14, Arg18, and
Lys28 (LicC numbering) in the signature sequence. Magnesium
is required for activity. In S. enterica RmlA and E. coli methylerythritol-4-phosphate cytidylyltransferase,
Mg2+ is proposed to position the nucleotide substrate
during the NMP transfer reaction and to stabilize the PPi
leaving group after the reaction (19, 21); thus, Mg2+ is
not thought to play a role in the catalytic mechanism. In the other two
structures, the magnesium binding site is undefined (18, 20). Several
positively charged residues that are not conserved in all of the NTP
transferase structures are proposed to be involved in catalysis of RmlA
and methylerythritol-4-phosphate cytidylyltransferase by providing a
favorable electrostatic environment, although their exact role is
unclear (19-21). Exceptions are Arg18 and
Lys28 (LicC numbering) in the signature sequence that bind
the triphosphate group of the nucleotide substrate to stabilize the
negative charge developed on the oxygens of the -phosphate in the
pentacoordinate transition state and the released PPi
product. We have determined the kinetic mechanism of LicC from S. pneumoniae and the structures of LicC and the
LicC·CDP-Cho·Mg2+ ternary complex. The structures
explain the specificity of LicC for CTP and identify the active site
residues involved in binding the product, CDP-choline, with magnesium.
We propose the mode of substrate binding and the direct role of the
magnesium in catalysis based on the kinetic data and structures.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Sources of supplies were Sigma (for CTP, CDP-Cho,
P-Cho, and seleno-L-methionine) and Amersham
Biosciences, Inc. (for phospho[methyl-14C]choline
(specific activity 55 mCi/mmol)). His-tagged native LicC was expressed
and purified as described previously (14). For metabolic incorporation
of selenomethionine into LicC, pET-15b containing the licC
gene was transformed into BL21-CodonPlus(DE3)-RIL-X (Stratagene), and
protein was expressed as described previously (22) and purified in the
same manner as the His-tagged native LicC. Protein concentration
was determined by the method of Bradford (23). All other chemicals were
reagent grade or better.
LicC Enzyme Assay--
The enzymatic activity of LicC under
different conditions was studied using the assay method described
previously (14). The apparent Km for CTP or P-Cho in
the presence of different concentrations of the second substrate was
determined. In a final volume of 50 µl, the LicC assay contained the
substrates, CTP and phospho[methyl-14C]choline (specific
activity 3.68 mCi/mmol), at the appropriate concentrations for each
study indicated in the figure legends, and 10 mM
MgCl2 in 150 mM bis-Tris-HCl, pH
7.0. LicC was added last to start the reaction. After incubation of the
reaction mixture at 37 °C for 10 min, the reaction was stopped by
the addition of 5 µl of 0.5 M EDTA. A 40-µl aliquot of
the reaction mixture was applied to a preabsorbent Silica Gel G plate,
which was developed with 95% ethanol/2% ammonium hydroxide (1:1,
v/v). The single product was visualized with a Bioscan Imaging detector
and migrated with the standard CDP-Cho. Furthermore, different
concentrations of either product (CDP-Cho and PPi) of the
LicC reaction were included in the assay to determine the order of the reaction.
Crystallization--
Se-Met LicC was concentrated to 23.3 mg/ml
in 50 mM Tris, pH 7.5, 1 mM dithiothreitol, 1 mM EDTA. The preliminary crystals of Se-Met LicC were
obtained from Hampton Research screening kits, and the refined
condition contained 0.1 M sodium citrate, 1.85 M ammonium sulfate, 0.2 M sodium/potassium
tartrate, pH 5.8, at 18 °C. Crystals appeared after several days,
which grew further for 1 week. These crystals were transferred to a
cryoprotectant solution that was made by adding 30% glycerol to the
mother liquor for data collection. Co-crystals of LicC and CDP-Cho were
grown by adding CDP-Cho and MgCl2 to the protein to a final
concentration of 10 mM each, and the mixture was incubated
overnight at 4 °C. The crystallization condition contained 0.4 M sodium acetate, 21% polyethylene glycol 4000, 0.1 M sodium cacodylate, pH 6.5, at 18 °C. The rectangular
crystals grew in 10 days. A cryoprotectant solution for cryodata
collection was made by adding 22.5% glycerol to the mother liquor.
Data Collection and Structure Determination--
Multiwavelength
anomalous dispersion data were measured from a single crystal of Se-Met
apo-LicC at beam line X8-C at the National Synchrotron Light Source,
equipped with an ADSC Quantum 4R detector operating at 100 K. Two
wavelengths near the selenium absorption edge, 0.9793 Å (the peak) and
0.9795 Å (the inflection point), were chosen by measuring the x-ray
absorption spectrum of the protein crystal. The data sets from both
wavelengths were collected, reduced, and scaled by the program
HKL 2000 (24). The crystals of apo-LicC belong to space group
P21 21 21 with unit cell dimensions
of a = 42.6 Å, b = 63.6 Å,
c = 122.4 Å. The program SOLVE was used to scale the
two wavelength data sets together, to locate selenium positions, and to
calculate the protein phases (25). Two of the four selenium atoms in
the LicC enzyme were confirmed. The program RESOLVE was used for
reciprocal space solvent flattening (26). The statistics of data
collection and phasing are summarized in Table
I. The atomic model was built using the programs Warp (27) and Xtalview (28), followed by
crystallographic refinement in the program XPLOR (29). The refinement
steps included simulated annealing, conjugated gradient minimization,
and individual B-factor refinement. The refinement statistics are shown
in Table II.
Complete diffraction data from a single crystal of the
LicC·CDP-Cho·Mg2+ complex were measured at beamline
19-BM at the Advanced Photon Source, equipped with a SBC-2 CCD x-ray
detector operating at 100 K. The program HKL 2000 (24) was used to
integrate and scale the data set. The crystals of the ternary complex
belonged to space group P1 with unit cell dimensions of
a = 48.2 Å, b = 69.0 Å,
c = 81.6 Å, = 93.4°, = 92.8°,
= 97.1°. The data collection statistics are summarized in
Table I. The structure of the CDP-choline-bound LicC was determined by
the molecular replacement method using the refined apo-enzyme as a
search model. The cross-rotation and translation functions and
Patterson correlation refinement were calculated using the program
XPLOR (29). Using the data between 15.0 and 4.0 Å, the rotation
function, followed by Patterson correlation refinement, gave four
outstanding solutions that correspond to four molecules of LicC.
Because any point can be taken as an origin in space group P1, we
rotated the search model according to the highest solution of rotation
function and considered this rotated molecule as the first molecule.
With fixing the first molecule, the orientations of the other three
molecules were determined by applying the three independent
noncrystallographic symmetry operations to the first molecule, and then
their positions relative to the first molecule were found by searching
the x, y, and z translations in the
unit cell. After the model, including all four molecules, was subjected
to rigid body refinement at the resolutions between 6.0 and 4.0 Å in
the program XPLOR, the resulting R factor was high (40.6%), suggesting
the conformational difference of the CDP-choline-bound structure from
the search model of the apo-enzyme structure. After the bulk solvent
contribution was made to the intensities of reflections at low
resolution, the high and low resolution limits were extended to 20 and
2.4 Å, respectively. Crystallographic refinement including simulated annealing, conjugate gradient minimization, and individual B-factor refinement was then performed at the extended resolutions. After the
crystallographic refinement, the electron density map was improved by
the noncrystallographic symmetry averaging method using the program DM
(30). The Fo Fc difference map
clearly showed the electron density of CDP-Cho·Mg2+ in
all four molecules, verifying the correct molecular replacement solutions. Several iterations of model building and the
crystallographic refinement gave the excellent refinement statistics
(Table II). Noncrystallographic restraints were applied to the main
chain of each molecule for simulated annealing refinement. The final structure contains four molecules of LicC (residues 4-231 in each of
four subunits).
 |
RESULTS |
Overview of the LicC Structure--
The apo-LicC structure reveals
a mixed seven-stranded -sheet flanked by three -helices on one
side ( 1, 2, and 6) and another three -helices on the
other ( 3, 4, and 5) (Fig. 1). The seven-stranded sheet has six parallel strands (strands 1, 2,
3, 4, 5, and 7), and strand 6 is antiparallel to others, representing the typical nucleotide-binding fold (31). Four additional
strands ( 5a, 5b, 5c, and 5d) located between strands 5
and 6, which are perpendicular to the seven-stranded -sheet, and
another four strands ( 1a and 1b, 4a, and 7a) are not part of the main -sheet. Comparison of the apo-LicC structure with known
structures in the Protein Data Bank using the DALI server (32) revealed
that the two best matches were with two members of the NTP transferase
superfamily: P. aeruginosa RmlA (Protein Data Bank code
1g0r, r.m.s. deviation 2.6 Å, C atoms of 218 residues) and GlmU
(Protein Data Bank code 1fwy, r.m.s. deviation 2.8 Å, C atoms of
214 residues). The structures of two additional enzymes that belong to
the NTP transferase superfamily were also compared using the program O
(33): S. enterica RmlA (Protein Data Bank code 1iin, r.m.s.
deviation 1.9 Å, C- atoms of 171 residues) and E. coli
methylerythritol-4-phosphate cytidylyltransferase (Protein Data Bank
code 1i52, r.m.s. deviation 1.7 Å, C- atoms of 131 residues). The
finding of these low r.m.s. deviation values indicates that LicC is
structurally similar to the three members of the NTP transferase
superfamily. The structural similarity along with the conservation of
the N-terminal signature sequence supports the classification of LicC
as a member of the NTP transferase superfamily (14). Among the three
members of the NTP transferase superfamily homologous to LicC, GlmU is
an uridyltransferase involved in the production of
UDP-N-acetylglucosamine, an essential precursor for the cell
wall and membrane biosynthesis in bacteria (18). RmlA is a
thymidylyltransferase and the first enzyme in the biosynthesis of
deoxy-TDP-L-rhamnose that is a component of the cell wall
in many bacteria (20). E. coli methylerythritol-4-phosphate
cytidylyltransferase is a cytidyltransferase involved in the
mevalonate-independent pathway for isoprenoid biosynthesis (19).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
Overall stereoview of the LicC
structure. Helices are shown in blue, strands in
green, and other secondary structural elements in
yellow. The core seven -stranded sheets and
flanking -helices on either sides are labeled as 1-7
and 1-6. Additional -strands that are not part of the
core sheet are labeled by alphabetizing after the preceding -strand
number. For example, the -strand inserted between 4 and 5 is
labeled as 4a. Figs. 1, 3, and 4 were produced by the
program RIBBONS (40).
|
|
The crystals of LicC·CDP-Cho·Mg2+ ternary complex
contain four molecules in an asymetric unit, assembled to form two
dimers. However, purified LicC behaves as a monomer (14), and the
apo-LicC structure contains one molecule per asymmetric unit, arguing
that the dimers arise from the crystallization condition for the
CDP-Cho·Mg2+ complex. The four molecules in the
asymmetric unit superimpose to one another with an r.m.s. deviation of
between 0.64 and 0.75 Å, illustrating that they have nearly identical
conformations. The hydrophilic nature of the dimer interface (~60%
of interactions) is also consistent with the conclusion that the
monomer is the biologically functional unit. Additionally, sequence
analysis of the NPT transferase superfamily members reveals that LicC
lacks the oligomerization domain at the C terminus. The structures of apo-LicC and the LicC·CDP-Cho·Mg2+ complex superimpose
with an r.m.s. deviation of 1.51 Å, indicating that only small
structural changes occur upon CDP-Cho·Mg2+ binding to LicC.
The LicC Active Site--
CDP-Cho·Mg2+ is bound in a
deep pocket with negative electrostatic potential (Fig.
2A). Bound Mg2+ is
located between the pyrophosphate group of CDP-Cho and the active site
pocket, neutralizing the charge repulsion between them. The negatively
charged residues lining the active site pocket of LicC include
Asp105, Asp107, Glu135,
Asp192, Glu216, and Asp218. Among
these residues, Asp107 and Glu216 are conserved
within the NTP transferase family members except GlmU and E. coli methylerythritol-4-phosphate cytidylyltransferase. In GlmU,
while Asp107 is conserved, Glu216 is changed to
Gly, and in E. coli methylerythritol-4-phosphate cytidylyltransferase, Asp107 and Glu216 are
replaced by Ala and Lys, respectively. Consistent with the conserved
number of negatively charged residues, the active site electrostatic
potential of LicC (Fig. 2A) and RmlA (Fig. 2B)
are highly negative. The GlmU active site (Fig. 2C) is
slightly less negatively charged compared with LicC and RmlA. In
contrast, the methylerythritol-4-phosphate cytidylyltransferase active
site (Fig. 2D) is positively charged.

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 2.
Solvent-accessible surface and electrostatic
surface potential. Red and blue represent
negative and positive electrostatic surface potential, respectively,
whereas white represents neutral electrostatic surface
potential. Bound ligands are shown with a ball
and stick representations.
A, the electrostatic potential of LicC with bound
CDP-Cho·Mg2+. B, the electrostatic potential
of RmlA from P. aeruginosa with bound
dTDP-D-glucose (PDB code 1g1l). C, the
electrostatic potential of GlmU with bound
UDP-N-acetylglucosamine (PDB code 1fwy). D, the
electrostatic potential of methylerythritol-4-phosphate
cytidylyltransferase from E. coli with bound CTP (PDB code
1i52). We used the coordinates of the CTP-bound structure in
D, because the product-bound structure is not available.
This figure was produced with the program GRASP (41).
|
|
Interaction of the cytosine base of CDP-Cho with the enzyme explains
the observed specificity of LicC for CTP (14). The O-2 oxygen of
the cytosine base is hydrogen-bonded to the amide nitrogen of
Ala13 and the hydroxyl group of Ser90, and the
N-4 nitrogen of the base is hydrogen-bonded to the carbonyl oxygens of
Tyr82 and Tyr85 (Fig.
3A). It is clear that the N-4
nitrogen interaction excludes binding of other pyrimidine bases
(i.e. thymine and uracil) because their corresponding atom
(i.e. O-4 oxygen) cannot form hydrogen bonds with the
carbonyl oxygens of Tyr82 and Tyr85. There is
no specific interaction of the C-5 and C-6 carbons of the cytosine base
to the protein. The pyrimidine ring is stacked between the loop of
strands 1 and 1a and the loop of strand 3 and helix 3,
suggesting that larger purine bases can, if not ideally, also fit
between these two loops. However, only the adenine base, and not the
guanine base, is allowed, because the N-6 nitrogen of the adenine base,
but not the O-6 oxygen of the guanine base, can form hydrogen bonds
with Tyr82 and Tyr85. Finally, the hydrogen
bond interactions of 2'- and 3'-hydroxyl groups of the ribose sugar
with the amide nitrogens of Gly14 and Ala106
and the carbonyl oxygen of Leu11 secure the base of CTP,
and potentially ATP, in the binding pocket.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
The CDP-Cho binding pocket.
A, interactions of the cytidine group of CDP-Cho with the
enzyme. Note that hydrogen bond interactions of the N-4 nitrogen of the
cytosine base with the carbonyl oxygens of Tyr82 and
Tyr85 confer the nucleotide specificity of LicC for CTP.
B, interactions of the diphosphocholine group of CDP-Cho and
Mg2+ with the enzyme. Six oxygen atoms from the side chains
of Asp107, Glu216, and Asp218, the
pyrophosphate of CDP-Cho, and a water molecule are octahedrally
arranged about Mg2+ (magenta). The side chain
electrons of Trp136, Tyr190, and
Asp192 interact with the trimethylammonium group of
CDP-Cho. This type of interaction is observed in other proteins that
recognize the trimethylammonium group of choline (34-36). The closest
distances between the side chains of three residues and the
trimethylammonium groups are 3.5, 3.7, and 3.2 Å, respectively.
|
|
It is known that the trimethylammonium group of choline is recognized
by electron-rich aromatic rings (34-36). Indeed, in the LicC·CDP-Cho·Mg2+ complex, the binding pocket of the
trimethylammonium group is formed by the aromatic rings of
Tyr190 and Trp136 and the carboxyl group of
Asp192. The side chains compensate for the positive charge
of the trimethyl ammonium group through a stabilizing interaction with
their electrons (Fig. 3B). We hypothesize that the
negative charge of Asp192 may also be a factor in binding
of the trimethylammonium group, because an electrostatic bond is
stronger than a cation- bond (37).
Magnesium is required for the catalytic activity of LicC (14). In the
LicC·CDP-Cho·Mg2+ structure, the magnesium atom is
fixed in space by interactions with six oxygen atoms, two oxygens from
each of the - and -phosphates of CDP-choline, the carboxyl groups
of Asp107, Glu216, and Asp218, and
a water molecule, forming an octahedral geometry (Fig. 3B). This bound water molecule is further hydrogen-bonded to the carboxyl group of Asp105. The -phosphate oxygen of CDP-Cho and
the carboxyl groups of Asp107 and Asp218, which
bind the magnesium, form hydrogen bonds with the amino group of
Lys28 in the signature sequence (Fig. 3B),
suggesting that Lys28 participates in orienting the side
chains of Asp107 and Asp218 for binding both
magnesium and the nucleotide substrate. The interaction between the
amino group of Lys28 and the -phosphate oxygen can
enhance the catalytic reaction rate by stabilizing the developing
negative charge in the pentacoordinate transition state. When the
corresponding Lys of NTP transferases from other organisms was mutated,
the catalytic activity was decreased (18, 19), which is consistent with
the proposed role of Lys28 of LicC in catalysis. A
-phosphate oxygen that does not bind magnesium is hydrogen-bonded to
the hydroxyl group of Tyr190 that also interacts with the
trimethylammonium group via its aromatic ring (Fig. 3B).
Structural Differences between LicC and
LicC·CDP-Cho·Mg2+--
The most significant change in
the secondary structural elements induced by CDP-Cho·Mg2+
binding involves the four strands ( 5a, 5b, 5c, and 5d)
located between strands 5 and 6. In the
LicC·CDP-Cho·Mg2+ structure, strands 5a and 5b
with their intervening loop become the continuous, long strand 5a,
and strands 5c and 5d with their intervening loop coalesce to
form strand 5c (Fig. 4A). These new, longer strands 5a and 5c are interconnected by a hydrogen bond network to form a two-stranded sheet.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Structural changes in the
LicC·CDP-Cho·Mg2+ ternary complex. A,
when CDP-Cho·Mg2+ binds to the apo-LicC
(cyan), conformational changes in four strands ( 5a,
5b, 5c, and 5d) occur, resulting in the formation of two
strands ( 5a and 5c, shown in red). First two strands
( 5a and 5b) are merged to be a new long strand 5a and the last
two strands ( 5c and 5d) to be a new long strand, 5c.
Additional conformational change occurs in 7a and its C-terminal
loop (red). The secondary structural elements of the
apo-LicC structure are labeled as in Fig. 1, and the new long strands
5a and 5c of the LicC·CDP-Cho·Mg2+ ternary
complex (red) are labeled and highlighted in an
open rectangular box. Carbons of
CDP-Cho are shown in yellow, and Mg2+ is shown
in magenta (ball and stick representations).
B, the side chain conformations of several residues
(gray in apo-LicC and blue in the
LicC·CDP-Cho·Mg2+ ternary complex) affected by binding
of CDP-Cho·Mg2+ are shown in ball and stick
representations. The salt bridge between Arg129 and
Glu216 in apo-LicC is broken in the
LicC·CDP-Cho·Mg2+ ternary complex due to the movements
of Glu216 along with Asp218 for interacting
with Mg2+, which are illustrated by arrows. Note
that upon binding of CDP-Cho·Mg2+, the side chains of
Trp136 and Tyr190 move inward to optimize the
fit for the trimethylammonium group of Cho as it is shown in Fig. 3.
C, Arg18 in apo-LicC is anchored to the bottom
of the active site by forming hydrogen bonds with the side chain of
Asp107 and the carbonyl oxygen of Ile217, and
in the LicC·CDP-Cho·Mg2+ ternary complex, the same
residue swings out and is exposed to solvent.
|
|
CDP-Cho·Mg2+ binding also alters the side chain positions
of several residues. Side chains of Glu216 and
Asp218 move toward bound magnesium by 7.4 and 3.8 Å,
respectively, to coordinate the magnesium (Fig. 4B). Since
Glu216 in the apoenzyme structure is salt-bridged to
Arg129, the movement of Glu216 disrupts the
salt bridge interaction with Arg129, displacing the
guanidinium group of Arg129, breaking the hydrogen bond
interaction of Arg129 with the amide nitrogen of
Gly211. The displaced guanidinium group of
Arg129 is hydrogen-bonded to the side chain of
Glu135. Also, the side chains of Trp136 and
Tyr190 move toward the trimethylammonium group of
CDP-choline. Arg129, Glu135, and
Trp136 are all located in the newly formed strand
5a.
Arg18 (LicC numbering) in the signature sequence of NTP
transferase structures interacts with the nucleotide triphosphate
(19-21). In the apo-LicC structure, the guanidinium group of
Arg18 points down to the active site pocket, forming a
hydrogen bond network with the carboxyl group of Asp107 and
the carbonyl oxygen of Ile217 (Fig. 4C). In
contrast, the guanidinium group is flipped out and exposed to solvent
in the LicC·CDP-Cho·Mg2+ complex (Fig. 4C).
Since the LicC·CDP-Cho·Mg2+ complex is the structure of
the enzyme intermediate immediately after the release of
PPi (see below), the solvent-exposed guanidinium group of
Arg18 may correspond to the conformational change that
facilitates the release of PPi to the solvent. The side
chain of the corresponding Arg in E. coli
methylerythritol-4-phosphate cytidylyltransferase forms hydrogen bonds
with the - and -phosphate oxygens of CTP (19). In LicC, after
adjusting the torsion angles of Arg18, similar interactions
can be formed between the side chain of Arg18 and the -
and -phosphate oxygens of CTP modeled using the CTP coordinates of
E. coli methylerythritol-4-phosphate cytidylyltransferase (Protein Data Bank code 1i52). This finding suggests that
Arg18 may be involved in the release of PPi and
offset the negative charge developed on the -phosphate oxygen of CTP
during the catalytic reaction.
Kinetic Mechanism for LicC--
A series of kinetic experiments
were performed to define the kinetic mechanism for LicC. Double
reciprocal plots of 1/v versus 1/[CTP] at
different concentrations of P-Cho (Fig.
5A) intersected far to the
left of the 1/v axis and far below the 1/[CTP] axis. The
same pattern is observed in case of 1/v versus
1/[P-Cho] in the presence of different concentrations of CTP (Fig.
5B). A cursory inspection of the graphs leaves the
impression that the lines are parallel, which would indicate a
ping-pong mechanism. However, they are not, and there are many cases of
sequential enzymes where lines appear to be parallel. In these cases,
the enzyme has a relatively high affinity for the leading substrate,
but because of the relative values of the other rate constants the
apparent Km value is much larger than the
equilibrium binding constant (38). Product inhibition studies were
performed to verify that LicC is a sequential enzyme and to establish
the order of addition of substrates. CDP-Cho is a competitive inhibitor with respect to CTP, whereas PPi is a mixed-type inhibitor
with respect to CTP (Fig. 6). These data
show that CTP and CDP-Cho bind to the same form of the enzyme. On the
other hand, both PPi and CDP-Cho are mixed-type inhibitors
with respect to P-Cho (Fig. 7). This
pattern of the product inhibition is characteristic of a sequential bi
bi reaction with CTP as the leading substrate and CDP-Cho as the last
product to leave, which is the same as the catalytic mechanism of
E. coli glucose-1-phosphate thymidylyltransferase, a
homologue of P. aeruginosa RmlA (39).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
LicC reaction kinetics mechanism.
A, the double reciprocal plots of 1/v
versus 1/[CTP] at different concentrations of P-Cho.
B, the double reciprocal plots of 1/v
versus 1/[P-Cho] at different concentrations of CTP. Both
groups of the apparently parallel double reciprocal plots intersected
far to the left of the 1/v axis and far below the
1/[CTP] or 1/[P-Cho] axis, characteristic for an ordered bi bi
mechanism. Kinetic data were obtained using the assay described under
"Experimental Procedures," and the error bars
present the range of data.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Product inhibition of LicC reaction with
varied CTP. A, double reciprocal plots of
1/v versus 1/[CTP] in the presence of different
concentrations of CDP-Cho revealed that CDP-Cho is a competitive
inhibitor for CTP. B, double reciprocal plots of
1/v versus 1/[CTP] in the presence of different
concentrations of PPi revealed that PPi is a
mixed-type inhibitor for CTP. The concentration of P-Cho (1 mM) was held constant in the experiments, which were
performed using the assay described under "Experimental
Procedures." Error bars indicate the range of
data.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
Product inhibition of the LicC reaction with
respect to P-Cho. A, double reciprocal plots of
1/v versus 1/[P-Cho] in the presence of
different concentrations of CDP-Cho revealed that CDP-Cho is a
mixed-type inhibitor with respect to P-Cho. B, double
reciprocal plots of 1/v versus 1/[P-Cho] in the
presence of different concentrations of PPi revealed that
PPi is a mixed-type inhibitor with respect to P-Cho. The
concentration of CTP (160 µM) was held constant in the
experiments. Kinetic data were obtained using the assay described under
"Experimental Procedures," and the error bars
present the range of data.
|
|
 |
DISCUSSION |
We propose a model for the catalytic cycle of LicC that is
consistent with the kinetic and structural data (Fig.
8). CTP·Mg2+ is the leading
substrate. The LicC nucleotide specificity for CTP is conferred by
specific interactions that include the N-4 nitrogen of the cytosine
base and the carbonyl oxygens of Tyr82 and
Tyr85, the CTP O2 oxygen with the amide
nitrogen of Ala13 and the hydroxyl group of
Ser90. The , -phosphate oxygens are proposed to form a
salt bridge with Arg18, which points into the active site
of LicC. The planar aromatic ring of CTP is sandwiched between the loop
of strands 1 and 1a and the loop of strand 3 and helix 3.
The side chains of Asp107, Glu216,
Asp218, and the -phosphate of CTP coordinate the
Mg2+. Movement of Glu216 breaks the salt bridge
with Arg129 that in turn forms hydrogen bond to
Glu135. This induces four -strands in LicC into coalesce
into two long -strands. This rearrangement causes the repositioning
of Trp136 and Tyr190 to optimize the binding of
the second substrate P-Cho and position the bound P-Cho for the CMP
transfer reaction. The structure is consistent with the reaction
occurring by in-line nucleophilic attack of the phosphate oxygen of
P-Cho on the -phosphate of CTP, similar to other members of the NTP
transferase superfamily. The first product released from the active
site is PPi, which may be facilitated by its interaction
with Arg18, which points away from the active site in the
product structure. CDP-Cho·Mg2+ is the final product
released from the enzyme, allowing the
Glu216·Arg129 salt bridge to reform and
regeneration of the apo-enzyme structure.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 8.
The LicC catalytic cycle. LicC operates
by a sequential ordered mechanism that is interpreted based on the
enzyme kinetics and the conformational differences between the
structure of apo-LicC and the LicC·CDP-Cho·Mg2+ ternary
complex. LicC first binds CTP·Mg2+, which triggers a
conformation change that breaks the salt bridge between
Glu216 and Arg129. This action reorganizes the
-sheet structure of the protein to allow Glu216 to
directly interact with the incoming Mg2+ (see
"Discussion"). The subsequent binding of P-Cho is facilitated by
the movement of Trp136 and Tyr190 to optimize the
interaction of the enzyme with the incoming trimethylammonium group of
P-Cho. Catalysis occurs in the ternary complex, and PPi is
released first, facilitated by the movement of Arg18.
CDP-Cho·Mg2+ is the last product released from the
enzyme, which allows the Glu216·Arg129 salt
bridge to reform and regenerate the apo-enzyme structure.
|
|
The structural changes in the LicC·CDP-Cho·Mg2+ ternary
complex are confined to the residues and secondary structural elements that create the binding sites for Mg2+ and the
trimethylammonium group of Cho. These important conformational changes initiate at the Mg2+ binding site and are
propagated to the binding site of the trimethylammonium group via four
strands ( 5a, 5b, 5c, and 5d). LicC binds Mg2+
by breaking the salt bridge between Glu216 and
Arg129 in the apo-enzyme to release Glu216 to
coordinate the Mg2+. The side chain of Glu135
forms a hydrogen bond with the side chain of Arg129,
compensating for the absence of Glu216. Breaking the salt
bridge triggers the rearrangement of four individual strands ( 5a,
5b, 5c, and 5d) into two longer strands ( 5a and 5c)
(Fig. 4A). This reorganization displaces the side chains of
Trp136 on strand 5a and Tyr190 on the loop
of helices 4 and 5 to position P-Cho for an in-line nucleophilic
attack of the phosphate oxygen of P-Cho on -phosphorus of CTP.
Phosphoethanolamine lacks the trimethylammonium group of P-Cho and
therefore can fit in the active site. However, the positioning of
phosphoethanolamine within the active site pocket for the CMP transfer
reaction is predicted to be less efficient than P-Cho, accounting for
the lower catalytic activity of LicC when phosphoethanolamine is the
substrate (14).
Our structures expand the understanding of the catalytic mechanism of
members of the NTP transferase superfamily by implicating Mg2+ as an integral component in catalysis. The
Mg2+ in previously determined NTP transferase structures is
postulated to stabilize the PPi leaving group, and thus
plays an indirect role in catalysis (19, 21). However, the
Mg2+ bound at the active site of the
LicC·CDP-Cho·Mg2+ structure suggests the direct
involvement of the Mg2+ in the catalytic mechanism of LicC.
We propose two direct roles for Mg2+ in NTP transferases.
First, the bound Mg2+ accelerates catalysis by positioning
the phosphate oxygen of P-Cho adjacent to the -phosphate of CTP to
align the incoming second substrate of in-line nucleophilic attack.
Second, the interactions of the positively charged Mg2+
works in concert with the side chains of Arg18 and
Lys28 to stabilize the developing negative charge in the
pentacoordinate transition state during CMP transfer.
The role of Arg18 and Lys28 in the in-line
nucleophilic substitution mechanism proposed for LicC is the same as
proposed for the structurally known members of the NTP transferase
family, GlmU, RmlA, and E. coli methylerythritol-4-phosphate
cytidylyltransferase. When the nucleotide and phosphosugar substrates
bind to GlmU to form the ternary complex, the proximity of the
substrates and the catalytic Arg18 (also Arg18
in LicC) aids the reaction by stabilizing a charged transition state.
In RmlA, three residues, Arg15, Lys162, and
Arg194, appear important in the catalytic mechanism.
Arg15 (Arg18 in LicC) also functions by
stabilizing the charged transition state, and Lys162 (not
conserved in LicC) interacts with the phosphate of the phosphosugar substrate to increase its nucleophilicity. The function of
Arg194 (not conserved in LicC) is less clear because the
side chain conformation is different in two RmlA structures such that
the side chain of Arg194 in S. enterica RmlA
interacts with the phosphate of the phosphosugar substrate, whereas its
side chain in P. aeruginosa RmlA does not. In E. coli methylerythritol-4-phosphate cytidylyltransferase, Arg20 and Lys27 (Arg18 and
Lys28 in LicC, respectively) interact with the
-phosphate of CTP and are considered to function in transition state
stabilization. Arg157 from the second subunit of the dimer
(not conserved in LicC) and Lys213 (Glu216 in
LicC that coordinates Mg2+) interact with the phosphate of
the phosphoalcohol substrate, increasing the nucleophilicity of the
phosphoalcohol during the catalytic reaction. Taken together, these
results suggest that Arg18 and Lys28 (LicC
numbering) in the signature sequence play a common role in transition
state stabilization and substrate activation in catalytic mechanism for
the NTP transferase family members.
The active sites of GlmU and RmlA have negative electrostatic potential
that is unfavorable for binding of the negatively charged substrates.
Mg2+-coordinating Asp107 and Glu216
in LicC correspond to Asp110 and Asp225 in RmlA
and Asp105 and Gly225 in GlmU. In RmlA, these
conserved Asp residues contribute a putative, LicC-like metal binding
site, but metal binding was not observed in the structures of RmlA (19,
21). Mg2+ may bind to Asp110 and
Asp225 of RmlA to function as catalytic metal. The side
chain of Asp110 in P. aeruginosa RmlA is within
hydrogen bond distance to the -phosphate oxygen of the nucleotide
substrate, and the charge repulsion between Asp110 and the
-phosphate of the nucleotide substrate must be compensated during
the catalytic reaction. In LicC, Mg2+ bound by
Asp107 and Glu216 neutralizes the negative
charges of the substrates and increasing the catalytic activity by
stabilizing the transition state. Interestingly, Mg2+-coordinating Asp107 and Glu216
in LicC are replaced by Ala108 and Lys213 in
E. coli methylerythritol-4-phosphate cytidylyltransferase, respectively. These two replacements not only explain why the active
site of E. coli methylerythritol-4-phosphate
cytidylyltransferase has positive electrostatic potential but also
suggest that this enzyme may not require the direct involvement of
Mg2+ for binding substrates and catalysis.
 |
ACKNOWLEDGEMENTS |
We thank the Protein Production Facility for
protein purification and preliminary crystallization trials. We also
thank Matthew Frank for technical assistance and Drs. Li-Wei Hung at
(National Synchrotron Light Source) and Rongguang Zhang (Advanced
Photon Source) for help with diffraction data collection.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants GM 45737 (to S. J.) and GM 34496 (to C. O. R.), Cancer Center (CORE) Support Grant CA 21765, and the American Lebanese Syrian Associated Charities.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1jyk and 1jyl) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
To whom correspondence should be addressed. Tel.:
901-495-3838; Fax: 901-495-3032; E-mail:
hee-won.park@stjude.org.
Published, JBC Papers in Press, November 12, 2001, DOI 10.1074/jbc.M109163200
 |
ABBREVIATIONS |
The abbreviations used are:
P-Cho, phosphocholine;
CDP-Cho, cytidyldiphosphocholine;
CCT, CTP:phosphocholine cytidylyltransferase;
r.m.s., root mean
square.
 |
REFERENCES |
| 1.
|
Fischer, W.,
Behr, T.,
Hartmann, R.,
Peter-Katalinic, J.,
and Egge, H.
(1993)
Eur. J. Biochem.
215,
851-857[Medline]
[Order article via Infotrieve]
|
| 2.
|
Tuomanen, E. I.,
and Masure, H. R.
(1997)
Microb. Drug Resist.
3,
297-308[Medline]
[Order article via Infotrieve]
|
| 3.
|
Cundell, D. R.,
Gerard, C.,
Idanpaan-Heikkila, I.,
Tuomanen, E. I.,
and Gerard, N. P.
(1996)
Adv. Exp. Med. Biol.
416,
89-94[Medline]
[Order article via Infotrieve]
|
| 4.
|
Weiser, J. N.,
Shchepetov, M.,
and Chong, S. T.
(1997)
Infect. Immun.
65,
943-950[Abstract]
|
| 5.
|
Weiser, J. N.,
Pan, N.,
McGowan, K. L.,
Musher, D.,
Martin, A.,
and Richards, J.
(1998)
J. Exp. Med.
187,
631-640[Abstract/Free Full Text]
|
| 6.
|
Lysenko, E. S.,
Gould, J.,
Bals, R.,
Wilson, J. M.,
and Weiser, J. N.
(2000)
Infect. Immun.
68,
1664-1671[Abstract/Free Full Text]
|
| 7.
|
Lysenko, E.,
Richards, J. C.,
Cox, A. D.,
Stewart, A.,
Martin, A.,
Kapoor, M.,
and Weiser, J. N.
(2000)
Mol. Microbiol.
35,
234-245[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Serino, L.,
and Virji, M.
(2000)
Mol. Microbiol.
35,
1550-1559[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Weiser, J. N.,
Goldberg, J. B.,
Pan, N.,
Wilson, L.,
and Virji, M.
(1998)
Infect. Immun.
66,
4263-4267[Abstract/Free Full Text]
|
| 10.
|
Novak, R.,
Charpentier, E.,
Braum, J. S.,
Park, E.,
Murti, S.,
Tuomanen, E.,
and Masure, R.
(2000)
Mol. Microbiol.
36,
366-376[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Bean, B.,
and Tomasz, A.
(1977)
J. Bacteriol.
130,
571-574[Abstract/Free Full Text]
|
| 12.
|
Whiting, G. C.,
and Gillespie, S. H.
(1996)
FEMS Microbiol. Lett.
143,
279-284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Zhang, J.-R.,
Idanpaan-Heikkila, I.,
Fischer, W.,
and Tuomanen, E. I.
(1999)
Mol. Microbiol.
31,
1477-1488[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Rock, C. O.,
Heath, R. J.,
Park, H.-W.,
and Jackowski, S.
(2001)
J. Bacteriol.
183,
4927-4931[Abstract/Free Full Text]
|
| 15.
|
Kalmar, G. B.,
Kay, R. J.,
Lachance, A.,
Aebersold, R.,
and Cornell, R. B.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
6029-6033[Abstract/Free Full Text]
|
| 16.
|
Tsukagoshi, Y.,
Nikawa, J.,
and Yamashita, S.
(1987)
Eur. J. Biochem.
169,
477-486[Medline]
[Order article via Infotrieve]
|
| 17.
|
Weber, C. H.,
Park, Y. S.,
Sanker, S.,
Kent, C.,
and Ludwig, M. L.
(1999)
Structure Fold. Des.
7,
1113-1124[Medline]
[Order article via Infotrieve]
|
| 18.
|
Brown, K.,
Pompeo, F.,
Dixon, S.,
Mengin-Lecreulx, D.,
Cambillau, C.,
and Bourne, Y.
(1999)
EMBO J.
18,
4096-4107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Richard, S. B.,
Bowman, M. E.,
Kwiatkowski, W.,
Kang, I.,
Chow, C.,
Lillo, A. M.,
Cane, D. E.,
and Noel, J. P.
(2001)
Nat. Struct. Biol.
8,
641-648[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Blankenfeldt, W.,
Asuncion, M.,
Lam, J. S.,
and Naismith, J. H.
(2000)
EMBO J.
19,
6652-6663[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Barton, W. A.,
Lesniak, J.,
Biggins, J. B.,
Jeffrey, P. D.,
Jiang, J.,
Rajashankar, K. R.,
Thorson, J. S.,
and Nikolov, D. B.
(2001)
Nat. Struct. Biol.
8,
545-551[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Yun, M.,
Park, C. G.,
Kim, J. Y.,
Rock, C. O.,
Jackowski, S.,
and Park, H. W.
(2000)
J. Biol. Chem.
275,
28093-28099[Abstract/Free Full Text]
|
| 23.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276A,
307-326
|
| 25.
|
Terwilliger, T.,
and Berendzen, J.
(1999)
Acta Crystallogr. Sec. D
55,
501-505[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Terwilliger, T.
(1999)
Acta Crystallogr. Sect. D
55,
1863-1871[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Perrakis, A.,
Sixma, T. K.,
Wilson, K. S.,
and Lamzin, W. S.
(1997)
Acta Crystallogr. Sec. D
53,
448-455[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
McRee, D. E.
(1998)
XtalView, version 3.2.1
, The Scripps Research Institute, La Jolla, CA
|
| 29.
|
Brünger, A. T.
(1992)
X-PLOR: A System for X-ray Crystallography and NMR, version 3.1
, Yale University Press, New Haven, CT
|
| 30.
|
Collaborative Computational Project 4.
(1994)
Acta Crystallogr. Sec. D
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Rossmann, M. G.,
Liljas, A.,
Branden, C.-I.,
and Bransazak, L. J.
(1975)
Evolutionary and Structural Relationship among Dehydrogenases
, Academic Press, Inc., New York
|
| 32.
|
Holm, L.,
and Sander, C.
(1997)
Nucleic Acids Res.
25,
231-234[Abstract/Free Full Text]
|
| 33.
|
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119
|
| 34.
|
Dougherty, D. A.,
and Stauffer, D. A.
(1990)
Science
250,
1558-1560[Abstract/Free Full Text]
|
| 35.
|
Padlan, E. A.,
Cohen, G. H.,
and Davies, D. R.
(1985)
Ann. Inst. Pasteur. Immunol.
136C,
271-276
|
| 36.
|
Thompson, D.,
Pepys, M. B.,
and Wood, S. P.
(1999)
Struct. Fold. Des
7,
169-177[Medline]
[Order article via Infotrieve]
|
| 37.
|
Novotny, J.,
Bruccoleri, R. E.,
and Saul, F. A.
(1989)
Biochemistry
28,
4735-4749[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Segel, I. H.
(1975)
Enzyme Kinetics
, John Wiley & Sons, New York
|
| 39.
|
Zuccotti, S.,
Zanardi, D.,
Rosano, C.,
Sturla, L.,
and Tonetti, M.
(2001)
J. Mol. Biol.
313,
831-843[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Carson, M.
(1997)
Methods Enzymol.
277,
493-505[Medline]
[Order article via Infotrieve]
|
| 41.
|
Nicholls, A.
(1992)
GRASP: Graphical Representation and Analysis of Surface Properties
, Columbia University, New York
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Baur, J. Marles-Wright, S. Buckenmaier, R. J. Lewis, and W. Vollmer
Synthesis of CDP-Activated Ribitol for Teichoic Acid Precursors in Streptococcus pneumoniae
J. Bacteriol.,
February 15, 2009;
191(4):
1200 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Kharat, D. Denapaite, F. Gehre, R. Bruckner, W. Vollmer, R. Hakenbeck, and A. Tomasz
Different Pathways of Choline Metabolism in Two Choline-Independent Strains of Streptococcus pneumoniae and Their Impact on Virulence
J. Bacteriol.,
September 1, 2008;
190(17):
5907 - 5914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jackowski and P. Fagone
CTP:Phosphocholine Cytidylyltransferase: Paving the Way from Gene to Membrane
J. Biol. Chem.,
January 14, 2005;
280(2):
853 - 856.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Pattridge, C. H. Weber, J. A. Friesen, S. Sanker, C. Kent, and M. L. Ludwig
Glycerol-3-phosphate Cytidylyltransferase: STRUCTURAL CHANGES INDUCED BY BINDING OF CDP-GLYCEROL AND THE ROLE OF LYSINE RESIDUES IN CATALYSIS
J. Biol. Chem.,
December 19, 2003;
278(51):
51863 - 51871.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|